Physician profile
Vikram Sharma
NPI 1104232412
$3,387.55
in general payments reported to CMS, 2019-2025
10 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $33.18 · 2021: $301 · 2022: $217 · 2023: $2,069 · 2024: $630 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $1,126 · Food and Beverage: $1,078 · Travel and Lodging: $480 · Education: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $1,126.43 |
| Food and Beverage | $1,077.50 |
| Travel and Lodging | $480.04 |
| Education | $153.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,139.77 | 2023-2025 | Farapulse, Watchman Flx, Rhythmia Mapping System |
| Abbott Laboratories | $588.24 | 2021-2023 | Ensite, Diamondback Coronary |
| Abiomed | $292.57 | 2020-2024 | Impella |
| Acist Medical Systems, INC. | $122.35 | 2024 | |
| Penumbra, INC. | $63.06 | 2023 | Indigo System |
| Getinge USA Sales, LLC | $51.02 | 2020-2022 | |
| Edwards Lifesciences Corporation | $45.43 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic, INC. | $33.22 | 2023-2024 | Corevalve Evolut R |
| Biotronik INC. | $28.47 | 2021-2022 | |
| Shockwave Medical, INC | $23.42 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikram Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.